This study examined the impact of prior authorization formularies on the likelihood that patients with schizophrenia will be arrested and incarcerated.
Riad Dirani, PhD
Advertisement
Articles by Riad Dirani, PhD
This study measures the impact of Medicaid formulary restrictions on the rate at which patients who failed on a drug therapy for schizophrenia return to the same therapy.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Tocilizumab-bavi for CAR-T-Induced CRS, Pediatric COVID-19
2
Special Report: The Oncology Care Model, 10 Years Later
3
Shields Health Solutions Partners With Baptist Health on Specialty Pharmacy
4
AI Model Challenges Genomic Classifiers in Early Breast Cancer Risk Stratification: Nancy Lin, MD
5